HR 1393
118th Congress
House
Crime and Law Enforcement
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Introduced: March 7, 2023
Introduced by:
Dean, Madeleine
Democratic
· Pennsylvania
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 17, 2023
Referred to the Subcommittee on Health.
Mar 7, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 7, 2023
Introduced in House
Plain-English summary
This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
3